{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:36:27Z","timestamp":1762497387179,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":206,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aaceclinicalcasereports.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AACE Clinical Case Reports"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.4158\/accr-2019-0176","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T17:16:05Z","timestamp":1583342165000},"page":"e62-e64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Primary Adrenal Insufficiency Secondary to Chronic Posaconazole Use"],"prefix":"10.1016","volume":"6","author":[{"given":"Daniela Pirela","family":"Araque","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Zuniga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro R.","family":"Ayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/ACCR-2019-0176_bb0010","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1542\/pir.36-3-92","article-title":"Adrenal insufficiency","volume":"36","author":"Auron","year":"2015","journal-title":"Pediatr Rev"},{"key":"10.4158\/ACCR-2019-0176_bb0015","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2019-0176_bb0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ando.2017.10.010","article-title":"Group 1. Epidemiology of primary and secondary adrenal insufficiency: prevalence and incidence, acute adrenal insufficiency, long-term morbidity and mortality","volume":"78","author":"Chabre","year":"2017","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.4158\/ACCR-2019-0176_bb0025","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1515\/dx-2019-0013","article-title":"Primary adrenal insufficiency in the United States: diagnostic error and patient satisfaction with treatment","volume":"6","author":"Regan","year":"2019","journal-title":"Diagnosis (Berl)"},{"key":"10.4158\/ACCR-2019-0176_bb0030","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/jc.2017-01928","article-title":"Primary adrenal insufficiency: managing mineralocorticoid replacement therapy","volume":"103","author":"Esposito","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/ACCR-2019-0176_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/cs0840001","article-title":"Cellular and intrarenal control of renin secretion","volume":"84","author":"Sk\u00f8tt","year":"1993","journal-title":"Clin Sci (Lond)"},{"key":"10.4158\/ACCR-2019-0176_bb0040","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1056\/NEJM197602122940703","article-title":"Role of hyperkalemia in the metabolic acidosis of isolated hypoaldosteronism","volume":"294","author":"Szylman","year":"1976","journal-title":"N Engl J Med"},{"key":"10.4158\/ACCR-2019-0176_bb0045","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/TCRM.S3329","article-title":"Posaconazole in the management of refractory invasive fungal infections","volume":"4","author":"Langner","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.4158\/ACCR-2019-0176_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14787210.7.2.165","article-title":"Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update","volume":"7","author":"Smith","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.4158\/ACCR-2019-0176_bb0055","first-page":"2170484","article-title":"Posaconazole-induced adrenal insufficiency in a case of chronic myelomonocytic leukemia","volume":"2018","author":"Miller","year":"2018","journal-title":"Case Rep Endocrinol"},{"key":"10.4158\/ACCR-2019-0176_bb0060","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mmcr.2016.10.002","article-title":"A case of rhino-orbital mucormycosis in diabetes with haematogenous cerebral spread","volume":"13","author":"Snaith","year":"2016","journal-title":"Med Mycol Case Rep"},{"key":"10.4158\/ACCR-2019-0176_bb0065","first-page":"e305","article-title":"Adrenal suppression secondary to interaction of combined inhaled corticosteroid and antifungal agent","volume":"4","author":"Pimentel","year":"2018","journal-title":"AACE Clin Case Rep"},{"key":"10.4158\/ACCR-2019-0176_bb0070","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1517\/17425255.2011.627854","article-title":"Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450","volume":"7","author":"Gubbins","year":"2011","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.4158\/ACCR-2019-0176_bb0075","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1182\/blood-2011-06-356261","article-title":"Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol","volume":"118","author":"Trottestam","year":"2011","journal-title":"Blood"},{"key":"10.4158\/ACCR-2019-0176_bb0080","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1517\/14656566.6.14.2407","article-title":"Management of adrenal insufficiency in different clinical settings","volume":"6","author":"Hahner","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.4158\/ACCR-2019-0176_bb0085","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/JOE-12-0310","article-title":"Fluconazole inhibits human adrenocortical steroidogenesis in vitro","volume":"215","author":"van der Pas","year":"2012","journal-title":"J Endocrinol"},{"key":"10.4158\/ACCR-2019-0176_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/toxsci\/kfl051","article-title":"The steroid hormone biosynthesis pathway as a target for endocrine-disrupting chemicals","volume":"94","author":"Sanderson","year":"2006","journal-title":"Toxicol Sci"},{"key":"10.4158\/ACCR-2019-0176_bb0095","doi-asserted-by":"crossref","first-page":"339.e1","DOI":"10.1016\/j.amjmed.2015.08.021","article-title":"Adrenal crisis: still a deadly event in the 21st century","volume":"129","author":"Puar","year":"2016","journal-title":"Am J Med"}],"container-title":["AACE Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052030047X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S237606052030047X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:31:37Z","timestamp":1762497097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S237606052030047X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S237606052030047X"],"URL":"https:\/\/doi.org\/10.4158\/accr-2019-0176","relation":{},"ISSN":["2376-0605"],"issn-type":[{"type":"print","value":"2376-0605"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Adrenal Insufficiency Secondary to Chronic Posaconazole Use","name":"articletitle","label":"Article Title"},{"value":"AACE Clinical Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/ACCR-2019-0176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}